IE
EVH icon

Israel Englander’s Evolent Health EVH Stock Holding History

Israel Englander’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-62,000
Closed -$1.75M – 6079
2024
Q3 		$1.75M Buy
+62,000
New +$1.6M ﹤0.01% 3818
2024
Q2 		– Sell
-30,300
Closed -$994K – 6055
2024
Q1 		$994K Buy
+30,300
New +$967K ﹤0.01% 4296
2019
Q1 		– Sell
-20,000
Closed -$399K – 4054
2018
Q4 		$399K Buy
+20,000
New +$463K ﹤0.01% 3090

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Israel Englander's EVH Position: Q2 2026 in Review

Israel Englander reduced its Evolent Health (EVH) stake by 19% in Q2 2026, selling an estimated $278K and leaving 303,343 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Israel Englander first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $65.5M in Q1 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Israel Englander held 303,343 shares of Evolent Health worth $1.64M as of Q2 2026.
  • Israel Englander sold 72,456 Evolent Health shares in Q2 2026, an estimated $278K.
  • Evolent Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3972 holding.
  • Israel Englander first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Israel Englander's Evolent Health position peaked at $65.5M in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.